
51 - 200 employees
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
Healthcare • Consulting • Manufacturing
Neurotech Pharmaceuticals, Inc. is a private biotechnology company focused on developing transformative therapies for chronic eye diseases, with a primary therapeutic focus on retinal disorders such as Macular Telangiectasia (MacTel) Type 2. The company develops and commercializes an Encapsulated Cell Therapy (ECT) platform that delivers Ciliary Neurotrophic Factor (CNTF) to protect photoreceptors and slow vision loss; its lead product ENCELTO (revakinagene taroretcel-lwey / NT-501) has received FDA approval for treating MacTel. Neurotech conducts R&D, clinical development, regulatory activities, and commercialization efforts targeting retinal neuroprotection and vision preservation.
Selected: 🆕 Date Added.
🕒 June 17
Senior Medical Science Liaison engaging with KOLs and healthcare professionals for Neurotech Pharmaceuticals. Establishing relationships and providing scientific support in the Midwest region.